Author:
Silbernagel Günther,Steiner Lars K.,Hollstein Tim,Fauler Günter,Scharnagl Hubert,Stojakovic Tatjana,Schumann Friederike,Bölükbasi Bediha,März Winfried,Steinhagen-Thiessen Elisabeth,Laufs Ulrich,Kassner Ursula
Subject
Cell Biology,Endocrinology,Biochemistry
Reference28 articles.
1. LDL-cholesterol: standards of treatment 2016: a German perspective;März;Am. J. Cardiovasc. Drugs.,2016
2. ESC/EAS guidelines for the management of dyslipidaemias;Catapano;Eur. Heart J.,2016
3. Evolocumab and clinical outcomes in patients with cardiovascular disease;Sabatine;N. Engl. J. Med.,2017
4. Schwartz, G. G., P. G. Steg, M. Szarek, D. L. Bhatt, V. A. Bittner, R. Diaz, J. M. Edelberg, S. G. Goodman, C. Hanotin, R. A. Harrington, . Alirocumab and cardiovascular outcomes after acute coronary syndrome. N. Engl. J. Med. Epub ahead of print. November 7, 2018; doi: 10.1056/NEJMoa1801174.
5. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis;Urban;J. Am. Coll. Cardiol.,2013
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献